PubRank

J M Gauthier

Author PubWeight™ 20.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998 10.01
2 Protein--protein interaction maps: a lead towards cellular functions. Trends Genet 2001 2.10
3 Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999 1.94
4 The papillomavirus E2 protein: a factor with many talents. Trends Biochem Sci 1991 1.44
5 A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 1999 1.43
6 c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity. Proc Natl Acad Sci U S A 2001 1.17
7 c-Jun inhibits transforming growth factor beta-mediated transcription by repressing Smad3 transcriptional activity. J Biol Chem 2000 1.11
8 [Effect of previous culture conditions and the presence of the rpoS gene on the survival of Salmonella typhimurium in sea water exposed to sunlight]. Can J Microbiol 2004 0.92
9 Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1. Lab Invest 1997 0.87
10 Ergonomics aspects of tree-planting using 'multipot' technology. Ergonomics 1993 0.84
11 [Hypersmolar diabetic coma (apropos of a case)]. Mars Med 1970 0.75
12 Carcinogenicity of procarbazine. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1974 0.75
13 [Biopsy of labial accessory salivary glands and tuberculosis]. Nouv Presse Med 1982 0.75
14 [Medico-economic assessment of neuroleptics in schizophrenia. Amisulpride versus haloperidol]. Encephale 1993 0.75
15 [Severe acute ethyl alcohol intoxication in the adult]. Rev Prat 1982 0.75
16 [Work loss and depression. Impact of fluoxetine]. Therapie 1993 0.75
17 First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugs. Int Clin Psychopharmacol 1987 0.75
18 [Record of 8 months of activity of the Marseilles poison Control Center]. Mars Med 1969 0.75
19 [Poison control centers and industrial medicine]. Arch Mal Prof 1970 0.75